CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 134 enrolled
Drug / intervention
Amoxicillin-Potassium Clavulanate +1 moredrug
Likely dose
Amoxicillin-Potassium Clavulanate 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01919411
NCT01919411Phase 4Completed

Prophylactic Antibiotics After Functional Endoscopic Sinus Surgery: a Randomized, Double-blind Placebo Controlled Trial

Massachusetts Eye and Ear Infirmary·interventional·Posted Aug 9, 2013·Updated Feb 25, 2020

In Brief

A Phase 4 clinical trial evaluating Amoxicillin-Potassium Clavulanate and Placebo for Sinusitis. Completed, enrolled 134 participants across 1 site.

Detailed Summary

Surgeons commonly prescribe post operative prophylactic antibiotics after sinus surgery. There is minimal data to support this. The investigators' study will aim to demonstrate that patients' quality of life and rate of post operative infection is the same whether they receive or do not receive antibiotics post operatively. The investigators hypothesis is that the disease specific quality of life of patients taking post-operative antibiotics is not inferior to the quality of life of patients who do not take post-operative antibiotics, and the rate of post-operative infections are the same. The investigators' specific aim is to compare validated symptom scores between post-operative populations who are given or are not given antibiotics. Rates of infections in the first 10 days after surgery will be recorded. The investigators will also compare endoscopic grades of sinus cavities during the post-operative follow up exams as an additional outcome measure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSinusitis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 9, 2013
Enrollment StartFeb 1, 2013
Primary CompletionSep 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 12.9 years ago

Interventions

Amoxicillin-Potassium Clavulanatedrug

Patients in this arm will receive 500mg of Amoxicillin-Potassium Clavulanate Combination orally twice a day for 7 days after surgery.

Placebodrug

Patients in this arm will receive 7 days of placebo after surgery.